What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
James J. Leyden spends much of his time researching Acne, Dermatology, Propionibacterium acnes, Microbiology and Antibiotics.
His Acne research is multidisciplinary, relying on both Antibiotic therapy, Surgery, Immunology and Alliance.
In general Dermatology study, his work on Photoaging often relates to the realm of In patient, thereby connecting several areas of interest.
In Propionibacterium acnes, James J. Leyden works on issues like Disease, which are connected to Disfigurement and Guideline.
His work on Erythromycin and Colonization is typically connected to Comedo as part of general Microbiology study, connecting several disciplines of science.
The study incorporates disciplines such as Drug resistance and Pharmacology in addition to Antibiotics.
His most cited work include:
- Staphylococcus aureus in the lesions of atopic dermatitis (670 citations)
- Topical tretinoin for photoaged skin (518 citations)
- New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group (504 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Dermatology, Acne, Antibiotics, Microbiology and Propionibacterium acnes.
His Dermatology study which covers Tretinoin that intersects with Tolerability.
His work carried out in the field of Acne brings together such families of science as Surgery, Clindamycin and Internal medicine, Adverse effect, Severity of illness.
James J. Leyden has included themes like Placebo and Endocrinology in his Internal medicine study.
His Staphylococcus aureus research extends to Microbiology, which is thematically connected.
James J. Leyden studied Propionibacterium acnes and Pharmacology that intersect with Minocycline.
He most often published in these fields:
- Dermatology (51.16%)
- Acne (34.30%)
- Antibiotics (16.28%)
What were the highlights of his more recent work (between 2009-2020)?
- Dermatology (51.16%)
- Acne (34.30%)
- Rosacea (5.23%)
In recent papers he was focusing on the following fields of study:
James J. Leyden focuses on Dermatology, Acne, Rosacea, Isotretinoin and Antibiotics.
His Dermatology study integrates concerns from other disciplines, such as Once daily and Tretinoin.
When carried out as part of a general Acne research project, his work on Propionibacterium acnes is frequently linked to work in Adapalene, therefore connecting diverse disciplines of study.
His work is dedicated to discovering how Propionibacterium acnes, Clindamycin are connected with Pharmacology and Antimicrobial effect and other disciplines.
His work deals with themes such as Dermabrasion, Surgery, Chemical peel and Pharmacokinetics, which intersect with Isotretinoin.
As a part of the same scientific study, he usually deals with the Antibiotics, concentrating on Antimicrobial and frequently concerns with Cutibacterium acnes and Maintenance therapy.
Between 2009 and 2020, his most popular works were:
- Guidelines of care for the management of acne vulgaris (441 citations)
- New insights into rosacea pathophysiology: A review of recent findings (171 citations)
- Large-scale worldwide observational study of adherence with acne therapy (111 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
James J. Leyden focuses on Acne, Dermatology, Isotretinoin, MEDLINE and Propionibacterium acnes.
The concepts of his Acne study are interwoven with issues in Severity of illness, Surgery and Antibiotics.
His Antibiotics study combines topics in areas such as Drug Utilization and Large population.
The various areas that he examines in his Dermatology study include Scars and Rating scale.
His research integrates issues of Guideline, Disease and Intensive care medicine in his study of MEDLINE.
The Propionibacterium acnes study combines topics in areas such as Health care, Clindamycin, Inflammation, Immunology and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
